{"DataElement":{"publicId":"6941881","version":"1","preferredName":"Neuroendocrine Neoplasm Present Type","preferredDefinition":"The text response that indicates the type of pancreatic neuroendocrine tumor present.","longName":"NROEND_TMR_PST_TYP","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"6973446","version":"1","preferredName":"Neuroendocrine Neoplasm Present","preferredDefinition":"A benign or malignant neoplasm composed of cells of neuroendocrine origin. Representative examples include paraganglioma, carcinoid tumor, and neuroendocrine carcinoma._Being or existing in a specified place or at the specified time.","longName":"4985525v1.0:2233878v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"4985525","version":"1","preferredName":"Neuroendocrine Neoplasm","preferredDefinition":"A benign or malignant neoplasm composed of cells of neuroendocrine origin. Representative examples include paraganglioma, carcinoid tumor, and neuroendocrine carcinoma.","longName":"C3809","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroendocrine Neoplasm","conceptCode":"C3809","definition":"An epithelial neoplasm with neuroendocrine differentiation. This category includes neuroendocrine tumors, neuroendocrine carcinomas, and paragangliomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E2B7374-A356-3BA5-E050-BB89AD431881","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94595D2C-1678-210D-E053-F662850A254D","latestVersionIndicator":"Yes","beginDate":"2019-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-07","modifiedBy":"HARTLEYG","dateModified":"2019-10-30","changeDescription":"Curated to support Neuroendocrine Content (Pancreatic)","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6941870","version":"1","preferredName":"Neuroendocrine Neoplasm Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6941870v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"65","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Glucagon-producing (glucagonoma)","valueDescription":"Glucagon-Producing","ValueMeaning":{"publicId":"6974960","version":"1","preferredName":"Glucagon-Producing","longName":"6974960","preferredDefinition":"Describes cells or tissues that produce glucagon.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glucagon-Producing","conceptCode":"C165279","definition":"Describes cells or tissues that produce glucagon.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"948209FB-5016-76E7-E053-F662850AD2B1","latestVersionIndicator":"Yes","beginDate":"2019-10-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-09","modifiedBy":"ONEDATA","dateModified":"2019-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"948209FB-502F-76E7-E053-F662850AD2B1","beginDate":"2019-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-09","modifiedBy":"ONEDATA","dateModified":"2019-10-09","deletedIndicator":"No"},{"value":"Insulin-producing (insulinoma)","valueDescription":"Insulin-Producing","ValueMeaning":{"publicId":"6974961","version":"1","preferredName":"Insulin-Producing","longName":"6974961","preferredDefinition":"Describes cells or tissues that produce insulin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Insulin-Producing","conceptCode":"C165278","definition":"Describes cells or tissues that produce insulin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"948209FB-503B-76E7-E053-F662850AD2B1","latestVersionIndicator":"Yes","beginDate":"2019-10-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-09","modifiedBy":"ONEDATA","dateModified":"2019-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"948209FB-5054-76E7-E053-F662850AD2B1","beginDate":"2019-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-09","modifiedBy":"ONEDATA","dateModified":"2019-10-09","deletedIndicator":"No"},{"value":"Other (specify)","valueDescription":"Other","ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C7BEC4-B568-70EE-E053-F662850A8FD6","beginDate":"2019-09-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Gastrin-producing (gastrinoma)","valueDescription":"Gastrin-Producing Neuroendocrine Tumor","ValueMeaning":{"publicId":"3249061","version":"1","preferredName":"Gastrin-Producing Neuroendocrine Tumor","longName":"3249061","preferredDefinition":"A gastrin-producing neuroendocrine tumor. It is usually located in the pancreas but it is also found at other anatomic sites, including the stomach and small intestine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrin-Producing Neuroendocrine Tumor","conceptCode":"C3050","definition":"A gastrin-producing neuroendocrine tumor. It is usually located in the pancreas but it is also found at other anatomic sites, including the stomach and small intestine.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-1910-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94594FFD-FCB6-2190-E053-F662850A0DDB","beginDate":"2019-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"Vasoactive intesting polypeptide (VIP)-producing (VIPoma)","valueDescription":"VIP-Producing Neuroendocrine Tumor","ValueMeaning":{"publicId":"4264969","version":"1","preferredName":"VIP-Producing Neuroendocrine Tumor","longName":"4264969","preferredDefinition":"An often clinically aggressive neuroendocrine tumor located in the pancreas or small intestine.  It is composed of cells containing vasoactive intestinal peptide.  It may cause intractable diarrhea and metabolic disturbances.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"VIP-Producing Neuroendocrine Tumor","conceptCode":"C26749","definition":"An often clinically aggressive neuroendocrine tumor located in the pancreas or small intestine.  It is composed of cells containing vasoactive intestinal peptide.  It may cause intractable diarrhea and metabolic disturbances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3C35-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94594FFD-FCCB-2190-E053-F662850A0DDB","beginDate":"2019-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"Somatostatin-producing (somatostatinoma)","valueDescription":"Somatostatin-Producing Neuroendocrine Tumor","ValueMeaning":{"publicId":"6973442","version":"1","preferredName":"Somatostatin-Producing Neuroendocrine Tumor","longName":"6973442","preferredDefinition":"A rare, usually malignant neuroendocrine tumor arizing from delta cells.  This neoplasm produces large amounts of somatostatin, which may result in a syndrome characterized by diarrhea, steatorrhea, weight loss, and gastric hyposecretion. Sixty percent are found in the pancreas and 40% in the duodenum or jejunum. The peak incidence occurs between 40 and 60 years of age; women are affected more than men by 2:1.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Somatostatin-Producing Neuroendocrine Tumor","conceptCode":"C3379","definition":"A rare, usually malignant neuroendocrine tumor arizing from delta cells.  This neoplasm produces large amounts of somatostatin, which may result in a syndrome characterized by diarrhea, steatorrhea, weight loss, and gastric hyposecretion. Sixty percent are found in the pancreas and 40% in the duodenum or jejunum. The peak incidence occurs between 40 and 60 years of age; women are affected more than men by 2:1.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94594FFD-FCD8-2190-E053-F662850A0DDB","latestVersionIndicator":"Yes","beginDate":"2019-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94594FFD-FCF1-2190-E053-F662850A0DDB","beginDate":"2019-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"Serotonin-producing (carcinoid)","valueDescription":"Carcinoid Tumor","ValueMeaning":{"publicId":"2956072","version":"1","preferredName":"Carcinoid Tumor","longName":"2956072","preferredDefinition":"Carcinoid tumor, also known as well differentiated endocrine neoplasm, is a slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis.  The tumor may show a variety of patterns, such as solid, trabecular, and acinar.  Electron microscopy shows small secretory granules.  Immunohistochemical studies reveal NSE, as well as chromogranin immunoreactivity.  Malignant histology (cellular pleomorphism, hyperchromatic nuclei, prominent nucleoli, necrosis, and mitoses) can occasionally be seen.  Such cases may have an aggressive clinical course.  Gastrointestinal tract and lung are common sites of involvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoid Tumor","conceptCode":"C2915","definition":"A slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis.  The tumor may show a variety of patterns, such as solid, trabecular, and acinar.  Electron microscopy shows small secretory granules.  Immunohistochemical studies reveal NSE, as well as chromogranin immunoreactivity.  Malignant histology (cellular pleomorphism, hyperchromatic nuclei, prominent nucleoli, necrosis, and mitoses) can occasionally be seen.  Such cases may have an aggressive clinical course.  Gastrointestinal tract and lung are common sites of involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76EBECE2-B719-A0E2-E040-BB89AD435984","latestVersionIndicator":"Yes","beginDate":"2009-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"94594FFD-FD4B-2190-E053-F662850A0DDB","beginDate":"2019-09-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92C7BEC4-B4C7-70EE-E053-F662850A8FD6","latestVersionIndicator":"Yes","beginDate":"2019-09-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-09-17","modifiedBy":"HARTLEYG","dateModified":"2019-10-30","changeDescription":"Curated to support Pancreatic Content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000177","version":"1","longName":"Neuroendocrine","context":"OCG"},{"publicId":"5777527","version":"1","longName":"Pancreatic","context":"OCG"}]}],"AlternateNames":[{"name":"OCG","type":"USED_BY","context":"OCG"}],"ReferenceDocuments":[{"name":"Indicate the functional type","type":"Preferred Question Text","description":"Indicate the functional type of neuroendocrine tumor","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92C80BAF-04F2-6E04-E053-F662850AE488","latestVersionIndicator":"Yes","beginDate":"2019-09-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-09-17","modifiedBy":"HARTLEYG","dateModified":"2019-11-27","changeDescription":"Curated to support Pancreatic Content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}